Related Experiment Video
Updated: Jun 13, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Jeffrey A Bluestone1, Kevan Herold, George Eisenbarth
1Diabetes Center and the Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA. jbluest@diabetes.ucsf.edu
Nature
|May 1, 2010
Summary
Type 1 diabetes, an autoimmune disorder, is increasingly understood through T cell research. Advances focus on balancing regulatory and effector T cells for potential preventative or curative therapies.
Area of Science:
- Immunology and Endocrinology
- Autoimmune Disease Research
Background:
- Type 1 diabetes is a global autoimmune disorder requiring lifelong insulin therapy.
- Disease management involves addressing numerous associated complications.
- Recent research has significantly advanced understanding of disease causes and treatments.
Purpose of the Study:
- To review current progress in Type 1 diabetes research.
- To highlight challenges in developing preventative or curative therapies.
- To discuss novel interventions being tested for Type 1 diabetes.
Main Methods:
- Integration of findings from rodent models of spontaneous diabetes and human studies.
- Analysis of the role of T cell subsets in disease pathogenesis.
- Review of emerging therapeutic strategies.
Main Results:
- The balance between regulatory and effector T cells is critical in determining disease risk, onset, and progression.
- Significant research advances have been made in the last decade.
- New interventions are under investigation to meet the need for preventative or curative treatments.
Conclusions:
- Understanding T cell dynamics is key to Type 1 diabetes management.
- Continued research is essential to overcome challenges and develop effective therapies.
- Novel interventions show promise for future preventative or curative treatments.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...